Phaos Technology Holdings (Cayman) POAS
NYSE POAS
$0.16 0.00 (-0.55%)
As of: Aug 20, 2026 · 3:58 PM EDT

Phaos Technology Holdings (Cayman) (POAS) Invested Capital (2024 - 2025)

Phaos Technology Holdings (Cayman)'s (POAS) quarterly Invested Capital came in at $44196.5 in Q4 2025, up 6.23% on a QoQ basis from $41604.3 in Q2 2025.

Phaos Technology Holdings (Cayman) (POAS) Invested Capital (2024 - 2025) Analysis & Trends

Phaos Technology Holdings (Cayman) (POAS) has 2 years of Invested Capital data on file, last reported at $44196.5 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 3.01 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 750.00 Mn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 1.79 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 1.71 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn -
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 2.00 Mn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 1.34 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 243.40 Mn
10 Phaos Technology Holdings (Cayman) 4.24 Mn 4.20 Mn - 44,196.51

Historic Data

Download Data
DateValue
Oct 31, 2025 44,196.51
Apr 30, 2025 41,604.26
Apr 30, 2024 327,030.04